BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,890,676 | -14.9% | 235,577 | +2.7% | 0.01% | -9.1% |
| Q2 2023 | $10,447,910 | +18.2% | 229,322 | +5.2% | 0.01% | +10.0% |
| Q1 2023 | $8,840,052 | -38.8% | 217,950 | -23.1% | 0.01% | -41.2% |
| Q4 2022 | $14,439,138 | -80.4% | 283,287 | -79.3% | 0.02% | -80.2% |
| Q3 2022 | $73,762,000 | -16.9% | 1,369,517 | -0.9% | 0.09% | -14.9% |
| Q2 2022 | $88,719,000 | -9.4% | 1,381,266 | +0.2% | 0.10% | +3.1% |
| Q1 2022 | $97,942,000 | -15.0% | 1,378,298 | +2.7% | 0.10% | -7.5% |
| Q4 2021 | $115,207,000 | +6.3% | 1,342,114 | -0.4% | 0.11% | 0.0% |
| Q3 2021 | $108,395,000 | +1.0% | 1,347,692 | +1.1% | 0.11% | +2.9% |
| Q2 2021 | $107,356,000 | -4.5% | 1,333,612 | +0.1% | 0.10% | -10.4% |
| Q1 2021 | $112,404,000 | +6.1% | 1,332,749 | +1.0% | 0.12% | -2.5% |
| Q4 2020 | $105,913,000 | -2.2% | 1,319,952 | -1.9% | 0.12% | -15.1% |
| Q3 2020 | $108,261,000 | -16.0% | 1,346,190 | -10.0% | 0.14% | -20.1% |
| Q2 2020 | $128,835,000 | +101.0% | 1,496,340 | +89.6% | 0.17% | +222.2% |
| Q1 2020 | $64,088,000 | +61.9% | 789,352 | +66.7% | 0.05% | +12.5% |
| Q4 2019 | $39,592,000 | -24.9% | 473,473 | -21.4% | 0.05% | -29.4% |
| Q3 2019 | $52,716,000 | +36.8% | 602,674 | +28.1% | 0.07% | -12.8% |
| Q2 2019 | $38,525,000 | -21.1% | 470,389 | -21.7% | 0.08% | -29.7% |
| Q1 2019 | $48,826,000 | -11.4% | 600,493 | -28.3% | 0.11% | -19.6% |
| Q4 2018 | $55,111,000 | -24.0% | 837,302 | -11.0% | 0.14% | -8.0% |
| Q3 2018 | $72,547,000 | -13.2% | 941,067 | -16.8% | 0.15% | -15.7% |
| Q2 2018 | $83,546,000 | -6.6% | 1,131,452 | -17.8% | 0.18% | -8.7% |
| Q1 2018 | $89,485,000 | -11.7% | 1,375,835 | -12.2% | 0.20% | -8.5% |
| Q4 2017 | $101,311,000 | -3.4% | 1,567,306 | -6.2% | 0.21% | -9.7% |
| Q3 2017 | $104,865,000 | -1.7% | 1,671,163 | -5.1% | 0.24% | -5.6% |
| Q2 2017 | $106,665,000 | +4.5% | 1,761,899 | -10.5% | 0.25% | +2.9% |
| Q1 2017 | $102,072,000 | +530.2% | 1,968,222 | +438.8% | 0.24% | +492.7% |
| Q4 2016 | $16,198,000 | -46.7% | 365,328 | -42.8% | 0.04% | -51.8% |
| Q3 2016 | $30,405,000 | -2.3% | 638,757 | -7.2% | 0.08% | -31.5% |
| Q2 2016 | $31,117,000 | -33.3% | 688,115 | -39.4% | 0.12% | -35.8% |
| Q1 2016 | $46,669,000 | -27.4% | 1,136,037 | -32.5% | 0.19% | -27.7% |
| Q4 2015 | $64,253,000 | +78.6% | 1,684,214 | +53.8% | 0.27% | +80.4% |
| Q3 2015 | $35,977,000 | -54.7% | 1,095,189 | -4.0% | 0.15% | -49.7% |
| Q2 2015 | $79,387,000 | -12.3% | 1,140,902 | -7.6% | 0.29% | -12.0% |
| Q4 2014 | $90,521,000 | -2.1% | 1,235,097 | -4.1% | 0.33% | -52.1% |
| Q3 2014 | $92,434,000 | -3.6% | 1,287,903 | -2.9% | 0.70% | +7.1% |
| Q2 2014 | $95,933,000 | +1.6% | 1,326,657 | +3.4% | 0.65% | +1.7% |
| Q1 2014 | $94,384,000 | +22.6% | 1,282,744 | +15.8% | 0.64% | +17.9% |
| Q4 2013 | $77,001,000 | -24.9% | 1,108,167 | -29.0% | 0.54% | -26.1% |
| Q3 2013 | $102,483,000 | – | 1,560,121 | – | 0.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |